These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25267425)

  • 1. Decade in review--peripheral vascular disease: 10 Years of breakthroughs in peripheral vascular disease.
    Creager MA
    Nat Rev Cardiol; 2014 Nov; 11(11):635-6. PubMed ID: 25267425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Angiology].
    Lawall H; Diehm C
    Med Klin (Munich); 2008 Apr; 103(4):198-209. PubMed ID: 18484204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures.
    Allemang MT; Rajani RR; Nelson PR; Hingorani A; Kashyap VS
    Ann Vasc Surg; 2013 Jan; 27(1):62-7. PubMed ID: 22981017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiplatelet and anticoagulant treatment after percutaneous transluminal angioplasty for peripheral arteriosclerosis. Survey of a Cochrane review].
    Lorenzen ND; Eldrup N; Laustsen J
    Ugeskr Laeger; 2007 Sep; 169(39):3279-82. PubMed ID: 17953885
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines for the endovascular treatment of peripheral vascular disease.
    van Marle IC; Veller M; Scholz L; Fourie P; Duncan I; Hellig F; Jardine R; ; ;
    S Afr Med J; 2005 Jul; 95(7 Pt 2):519-26. PubMed ID: 16156425
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet therapy for vascular interventions.
    Comerota AJ; Thakur S
    Perspect Vasc Surg Endovasc Ther; 2008 Mar; 20(1):28-35. PubMed ID: 18388025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing role of interventional cardiologists for peripheral vascular disease.
    Nfor T; Allaqaband S; Bajwa T
    Curr Probl Cardiol; 2014 Aug; 39(8):255-311. PubMed ID: 25059431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The year in cardiology 2014: peripheral circulation.
    Aboyans V; Brodmann M; De Carlo M; Clement D; Mazzolai L; van Bortel L; van Sambeek MR; Vlachopoulos C;
    Eur Heart J; 2015 Mar; 36(10):591-7. PubMed ID: 25559131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy in peripheral arterial occlusive disease.
    Jackson MR; Clagett GP
    Chest; 1998 Nov; 114(5 Suppl):666S-682S. PubMed ID: 9822070
    [No Abstract]   [Full Text] [Related]  

  • 10. Current endovascular treatment of peripheral arterial disease.
    Mardikar HM; Mukherjee D
    Prog Cardiovasc Nurs; 2007; 22(1):31-7. PubMed ID: 17342004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral arterial disease and the hospitalist: the rationale for early detection and optimal therapy.
    Deitelzweig SB; Hoekstra JW
    J Hosp Med; 2008 Mar; 3 Suppl 2():S4-8. PubMed ID: 18438803
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
    Dörffler-Melly J; Koopman MM; Prins MH; Büller HR
    Cochrane Database Syst Rev; 2005 Jan; (1):CD002071. PubMed ID: 15674891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-platelet agents in peripheral vascular surgery].
    Van Damme H; David JL; Limet R
    Rev Med Liege; 1999 Feb; 54(2):109-17. PubMed ID: 10221064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.
    Goli RR; Contractor MM; Nathan A; Tuteja S; Kobayashi T; Giri J
    Curr Atheroscler Rep; 2017 Nov; 19(12):56. PubMed ID: 29103068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid surgical and endovascular therapy in multifocal peripheral TASC D lesions: up to three-year follow-up.
    Nishibe T; Kondo Y; Dardik A; Muto A; Koizumi J; Nishibe M
    J Cardiovasc Surg (Torino); 2009 Aug; 50(4):493-9. PubMed ID: 19734834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with aspirin resistance in patients premedicated with aspirin and clopidogrel for endovascular neurosurgery.
    Reavey-Cantwell JF; Fox WC; Reichwage BD; Fautheree GL; Velat GJ; Whiting JH; Chi YY; Hoh BL
    Neurosurgery; 2009 May; 64(5):890-5; discussion 895-6. PubMed ID: 19287328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of patients after endovascular interventions for peripheral artery disease.
    Sobieszczyk P; Eisenhauer A
    Circulation; 2013 Aug; 128(7):749-57. PubMed ID: 23940389
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment protocol of cerebral vascular accident].
    Biller J
    Rev Neurol; 1997 Jan; 25(137):114. PubMed ID: 9091192
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal Antiplatelet Therapy in Moderate to Severe Asymptomatic and Symptomatic Carotid Stenosis: A Comprehensive Review of the Literature.
    Murphy SJX; Naylor AR; Ricco JB; Sillesen H; Kakkos S; Halliday A; de Borst GJ; Vega de Ceniga M; Hamilton G; McCabe DJH
    Eur J Vasc Endovasc Surg; 2019 Feb; 57(2):199-211. PubMed ID: 30414802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.